Navigation Links
Evolution follows few of the possible paths to antibiotic resistance

Darwinian evolution follows very few of the available mutational pathways to attain fitter proteins, researchers at Harvard University have found in a study of a gene whose mutant form increases bacterial resistance to a widely prescribed antibiotic by a factor of roughly 100,000. Their work indicates that of 120 harrowing, five-step mutational paths that theoretically could grant antibiotic resistance, only about 10 actually endow bacteria with a meaningful evolutionary advantage.

The research is published in the journal Science.

"Just as there are many alternate routes one might follow in driving from Boston to New York, one intrinsic property of DNA is that very many distinct mutational paths link any two variants of a gene," says lead author Daniel M. Weinreich, a research associate in Harvard's Department of Organismic and Evolutionary Biology. "Although this fact has been recognized for at least 35 years, its implications for evolution by natural selection have remained unexplored. Specifically, it is of great interest to determine whether natural selection regards these many mutational paths equivalently."

Weinreich and colleagues generated a series of mutants found along all 120 possible mutational trajectories involving the gene coding for the enzyme beta-lactamase, which in altered form can serve to inactivate antibiotics including penicillin and cefotaxime. Analyzing how well each variant protected host Escherichia coli cells against treatment with various concentrations of antibiotic, the scientists found that only a very small fraction of these pathways confer ever-increasing resistance in pathogenic microbes, and are therefore relevant to natural selection.

Resistance-granting mutations of beta-lactamase occur in a five-step process, with the 120 possible mutational paths representing all the possible ways in which these five point mutations can occur. Fully 102 of the 120 trajectories are inaccessible to natural selectio

Source:Harvard University

Page: 1 2

Related biology news :

1. To Stop Evolution: New Way Of Fighting Antibiotic Resistance Demonstrated By Scripps Scientists
2. Evolution of taste receptor may have shaped human sensitivity to toxic compounds
3. Evolution of life on Earth may hold key to finding life in outer space
4. Evolutionary conservation of a mechanism of longevity from worms to mammals
5. Evolutionary biology research techniques predict cancer
6. Evolutionary shifts in olfactory sensitivities in fruit flies
7. Evolution mystery: Spider venom and bacteria share same toxin
8. Evolution of irreducible complexity explained
9. Evolutionary scrap-heap challenge: Antifreeze fish make sense out of junk DNA
10. Evolutionary forces explain why women live longer than men
11. Evolution reveals an independent route for diversity in animal form
Post Your Comments:
TAG: Evolution follows few the possible paths antibiotic resistance

(Date:10/2/2015)... , Oct. 02 2015 ... the "Enforcing the Law Using Biometrics" ... ) has announced the addition of the ... their offering. --> Research and Markets ... the "Enforcing the Law Using Biometrics" ...
(Date:9/30/2015)... , Sept. 30, 2015  The U.S. Court of ... another key ruling in favor of Crossmatch ™, ... fingerprint scanner company Suprema and its U.S. partner Mentalix ... a trade provision that declares it unlawful to engage ... infringing two of Crossmatch,s patents, the 5,900,993 patent and ...
(Date:9/29/2015)... is excited to be named one of the first 100 ... announcement was recently made at an invite-only IBM Watson: ... Francisco , where iDAvatars presented a demo of its ... "It is both an honor and a privilege to be ... the cognitive power of IBM Watson in our product, which ...
Breaking Biology News(10 mins):
... Energy (DOE),s Joint BioEnergy Institute (JBEI) have identified a potential ... diesel engines but would be clean, green, renewable and produced ... a JBEI research team engineered strains of two microbes, a ... a member of the terpene class of chemical compounds that ...
... Clemson University researchers recently reported finding a new class ... how cells repair damaged DNA. The finding from Cao,s ... with computational chemist Brian Dominy appeared in the Sept. ... "A new family of deamination repair enzymes in ...
... Five new research projects announced today (27 September) by ... to overcome some of the fundamental limitations of photosynthesis ... the sun. This research could lead to major increases ... of renewable chemicals. Just over 2M has been ...
Cached Biology News:
(Date:10/8/2015)... Oct. 8, 2015  ATCC, the premier global biological ... has been selected by The Michael J. Fox Foundation ... to academic, pharmaceutical, and biotechnology organizations committed to speed ... the United States , and more than 5 ... the United States , and more than 5 ...
(Date:10/8/2015)... Maryland , October 8, 2015 ... .   --> Goldman Small ... in the small cap and microcap sectors, announced ... research report on PharmaCyte Biotech, Inc. (OTCQB - ... focused on developing and preparing treatments for cancer ...
(Date:10/8/2015)... WILMINGTON, Del. , Oct. 8, 2015 /PRNewswire/ ... of CRISPR-Cas technologies for genome editing, jointly announced ... DuPont and Caribou have cross-licensed their respective patent portfolios, ... CRISPR-Cas technology applications in major row crops, and ... applications. --> ...
(Date:10/8/2015)... , Oct. 8, 2015  Today the Wyss Institute ... launch of its start-up company Opsonix Inc. ... Harvard,s Office of Technology Development (OTD) and ... sepsis therapy for clinical use. ... least a million people every year in the U.S. ...
Breaking Biology Technology:
... Corp.,(Nasdaq: GENZ ) today announced that the ... for Renvela(TM) (sevelamer carbonate) for,the control of serum ... Renvela is a next-generation version of Renagel(R) (sevelamer,hydrochloride), ... "Since its approval in 1998, Renagel has ...
... Capital Holdings Asia and,its co-investors today announced that ... Corporation, the world,s largest privately held,crop- protection and ... 250 billion (US$2.2 billion). The sale will culminate ... market private,equity firm with investment teams in Japan, ...
... Oct. 22 AMDL, Inc. (Amex:,ADL), headquartered ... and Jilin, China, through its wholly owned ... biopharma company that,engages in the development, manufacture ... AMDL announced today that its,management will present ...
Cached Biology Technology: